No Yes Ok

Archive

« Older Entries Newer Entries »

LSP: A European Venture Fund Invests in the Economics of Medtech Tuesday, November 17th, 2015
Amsterdam, 17 November 2015 – For a recent in-depth article on the LSP Health Economics Fund in The Medtech Strategist’s October issue, David Cassak spoke to LSP partner Anne Portwich. They discussed LSP’s strat [...]
LSP’s portfolio company Curetis raises EUR 40 million in successful Euronext IPO Wednesday, November 11th, 2015
Amsterdam, the Netherlands - 12 November 2015 - Our portfolio company Curetis N.V., a developer of advanced molecular diagnostic assays for severe infectious diseases in hospitalized patients, raised € 40 m [...]
Xeltis completed second feasibility clinical trial on bioabsorbable cardiovascular device technology Tuesday, November 10th, 2015
Xeltis developing first cardiac valves and vessels designed to allow endogenous tissue restoration   Zurich, Switzerland, 10 November 2015 – Xeltis has successfully completed its second feasibility trial in [...]
Probiodrug announces pricing of a EUR 13.5 million private placement of new shares Thursday, November 5th, 2015
NOT FOR PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA   HALLE/SAALE, Germany, 5 November 2015 - Probiodrug AG (the "Company") (Euronext Amsterdam: PBD), a biopharmaceuti [...]
LSP co-leads Luxendo Series A financing round Wednesday, October 14th, 2015
Amsterdam, The Netherlands, October 14, 2015 – Luxendo, a start-up company launched by the European Molecular Biology Laboratory (EMBL) and its technology transfer arm EMBLEM Technology Transfer (EMBLEM) in Heidelbe [...]
LSP’s Clemens Van Blitterswijk receives the prestigious Huibregtsen Prize for 2015 Wednesday, October 7th, 2015
Amsterdam, the Netherlands - 7th October 2015 - Clemens van Blitterswijk, partner at LSP (Life Sciences Partners), the specialist healthcare investment firm, has won the prestigious Huibregtsen Prize 2015 for the deve [...]
LSP's portfolio company Seahorse Bioscience to be acquired by Agilent Technologies Tuesday, September 15th, 2015
Amsterdam - 14 September 2015 - LSP (Life Sciences Partners), a leading European investor in health care, announces that its portfolio company, Seahorse Bioscience, a leader in providing instruments and assay kits for [...]
Merus enters into 72.8 million euro series C financing led by Sofinnova Ventures and Novo A/S Wednesday, August 26th, 2015
UTRECHT, Netherlands, Aug. 26, 2015 /PRNewswire/ -- Merus B.V., a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced that it has entered into an agreement wi [...]
Kiadis Pharma announces maiden Financial Results for the six months ended 30 June 2015 Tuesday, August 25th, 2015
Amsterdam, The Netherlands, August 25, 2015 – Kiadis Pharma N.V. (“Kiadis Pharma” or “Company”) (Euronext Amsterdam and Brussels: KDS), a recently-listed clinical stage biopharmaceutical company developi [...]
LSP invests in Kuros, a late-stage sealant and orthobiologics company Tuesday, August 18th, 2015
Amsterdam, The Netherlands, 18 August 2015. LSP (Life Sciences Partners), a leading European investor in health care, announces its investment in Kuros, a private, late-stage  company developing novel, biomaterial ba [...]

« Older Entries Newer Entries »

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
back to archive overview
Follow us

No Yes Ok

Archive

« Older Entries Newer Entries »

LSP: A European Venture Fund Invests in the Economics of Medtech Tuesday, November 17th, 2015
Amsterdam, 17 November 2015 – For a recent in-depth article on the LSP Health Economics Fund in The Medtech Strategist’s October issue, David Cassak spoke to LSP partner Anne Portwich. They discussed LSP’s strat [...]
LSP’s portfolio company Curetis raises EUR 40 million in successful Euronext IPO Wednesday, November 11th, 2015
Amsterdam, the Netherlands - 12 November 2015 - Our portfolio company Curetis N.V., a developer of advanced molecular diagnostic assays for severe infectious diseases in hospitalized patients, raised € 40 m [...]
Xeltis completed second feasibility clinical trial on bioabsorbable cardiovascular device technology Tuesday, November 10th, 2015
Xeltis developing first cardiac valves and vessels designed to allow endogenous tissue restoration   Zurich, Switzerland, 10 November 2015 – Xeltis has successfully completed its second feasibility trial in [...]
Probiodrug announces pricing of a EUR 13.5 million private placement of new shares Thursday, November 5th, 2015
NOT FOR PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA   HALLE/SAALE, Germany, 5 November 2015 - Probiodrug AG (the "Company") (Euronext Amsterdam: PBD), a biopharmaceuti [...]
LSP co-leads Luxendo Series A financing round Wednesday, October 14th, 2015
Amsterdam, The Netherlands, October 14, 2015 – Luxendo, a start-up company launched by the European Molecular Biology Laboratory (EMBL) and its technology transfer arm EMBLEM Technology Transfer (EMBLEM) in Heidelbe [...]
LSP’s Clemens Van Blitterswijk receives the prestigious Huibregtsen Prize for 2015 Wednesday, October 7th, 2015
Amsterdam, the Netherlands - 7th October 2015 - Clemens van Blitterswijk, partner at LSP (Life Sciences Partners), the specialist healthcare investment firm, has won the prestigious Huibregtsen Prize 2015 for the deve [...]
LSP's portfolio company Seahorse Bioscience to be acquired by Agilent Technologies Tuesday, September 15th, 2015
Amsterdam - 14 September 2015 - LSP (Life Sciences Partners), a leading European investor in health care, announces that its portfolio company, Seahorse Bioscience, a leader in providing instruments and assay kits for [...]
Merus enters into 72.8 million euro series C financing led by Sofinnova Ventures and Novo A/S Wednesday, August 26th, 2015
UTRECHT, Netherlands, Aug. 26, 2015 /PRNewswire/ -- Merus B.V., a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced that it has entered into an agreement wi [...]
Kiadis Pharma announces maiden Financial Results for the six months ended 30 June 2015 Tuesday, August 25th, 2015
Amsterdam, The Netherlands, August 25, 2015 – Kiadis Pharma N.V. (“Kiadis Pharma” or “Company”) (Euronext Amsterdam and Brussels: KDS), a recently-listed clinical stage biopharmaceutical company developi [...]
LSP invests in Kuros, a late-stage sealant and orthobiologics company Tuesday, August 18th, 2015
Amsterdam, The Netherlands, 18 August 2015. LSP (Life Sciences Partners), a leading European investor in health care, announces its investment in Kuros, a private, late-stage  company developing novel, biomaterial ba [...]

« Older Entries Newer Entries »

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
back to archive overview
X

MONTHLY REPORTS

Here you can subscribe for the monthly report of the LSP Life Sciences Fund